Safety Reporting and Pharmacovigilance for CRCs | Training Course
Safety Reporting and Pharmacovigilancefor CRCs
Of everything a CRC does, safety reporting carries the highest stakes. A missed adverse event, a late SAE report, or a miscategorized severity assessment can have direct consequences for participant safety and regulatory compliance. This course provides standalone, deep-dive training on the CRC's safety reporting responsibilities -- from recognizing that something has gone wrong, through documentation and grading, to timely reporting and follow-up. Safety reporting is too important to be a single module in a broader course. It deserves, and receives, its own dedicated curriculum.
Studied within the Clinical Research Coordinator track. One payment of $249 USD covers all eight courses and the certificate.
Modules
7
Lessons
28
Knowledge checks
7
Study time
~about 11h
Final exam50 questions · 80% to pass · 90 minutes · up to 3 attemptsICH E6(R3)Intermediate
What you will be able to do
01Identify adverse events through systematic assessment during study visits, telephone contacts, and participant self-reports
02Classify adverse events by severity (mild, moderate, severe), seriousness (SAE criteria), expectedness, and relationship to study intervention
03Document adverse events with the clinical detail required for causality assessment, regulatory reporting, and participant safety monitoring
04Execute SAE reporting procedures within required timelines (typically 24 hours for initial report), coordinating with the investigator for medical assessment
05Process safety communications from the sponsor including IB updates, DSMB recommendations, and safety letters
06Apply the pharmacovigilance framework of ICH E6(R3) Annex 1, Section 2.7 and understand how CRC reports contribute to the broader safety signal detection system
Seven modules,one final exam.
Seven modules and twenty-eight lessons, each module closing with a knowledge check, and a final exam to complete the course.
A knowledge check closes every module
FreeTwo lessons are open to read now
Pass the final exam at 80% to complete the course
IFoundations of safety reporting4 lessons · knowledge check
1.1Why safety reporting matters: from site reports to regulatory signals
1.2The regulatory framework: ICH E6(R3) Section 2.7, ICH E2A, and FDA requirements
1.3The CRC's role in the safety reporting chain
1.4Definitions that matter: adverse event, serious adverse event, SUSAR, and the distinctions between them
5.1Recognizing an SAE: the moment awareness triggers the clock
5.2Initial SAE reporting: the 24-hour timeline and what the initial report must contain
5.3SAE follow-up reports: updates, resolution, and final outcomes
5.4SAE reporting for different scenarios: hospitalizations, deaths, and pregnancy
VISafety communications and ongoing vigilance4 lessons · knowledge check
6.1Investigator's Brochure updates: what changed and what it means for your site
6.2Sponsor safety letters and CIOMS/MedWatch reports
6.3DSMB and DMC communications: when the data monitoring committee speaks
6.4IRB/IEC reporting of safety information: meeting your institutional obligations
VIIBuilding a safety culture at your site4 lessons · knowledge check
7.1Safety reporting training for the site team: what everyone needs to know
7.2Safety reporting systems: tracking, reminders, and quality checks
7.3Learning from safety events: using AE patterns to improve participant care
7.4The intersection of safety reporting and quality management
Final Exam: Safety Reporting and Pharmacovigilance for CRCs50 questions · 80% to pass · 90 minutes · up to 3 attempts
Read two lessonsbefore you enroll.
Both are open now, exactly as enrolled learners read them. Every lesson in the course is written, cited and narrated the same way.
Module II · Lesson 224 min
Physical assessment and vital sign changes as AE indicators
Learn when vital sign changes and physical examination findings become reportable adverse events through clinical significance assessment and protocol-specific thresholds.
Seriousness criteria: the SAE triggers you must know
Apply the seven SAE seriousness criteria in operational depth, including the important medical event clause and hospitalization nuances that challenge even experienced CRCs.
Each point links back to its section of the guideline.
Narrated end to end
Listen when you can’t sit down to read.
Saves your place
Pick up exactly where you stopped.
Studied as part ofthe CRC track.
Safety Reporting and Pharmacovigilance for CRCs is the seventh of eight courses in the Clinical Research Coordinator track. It is not sold on its own: one enrollment opens every course, every final exam and the certificate.
Clinical Research Coordinator
Specialized training for clinical trial coordination and site operations
Courses
8
Lessons
226
Study time
~100 h
Score 80% or higher on every final exam and your credential is issued, with the printable certificate included.
$249 USDOne payment for the whole track. Access does not expire.
How it is enrolled in, what the exam asks, and what you can read first.
Can I take this course on its own?
Not separately. Safety Reporting and Pharmacovigilance for CRCs is the seventh course in the Clinical Research Coordinator track, and the track is enrolled in as one: all eight courses, every final exam and the certificate, for one payment of $249 USD.
What does the final exam ask?
Fifty questions in 90 minutes, with 80% needed to pass, and up to three attempts. Each module also closes with a knowledge check.
Can I read any of it before I enroll?
Yes. Two lessons are open now: “Physical assessment and vital sign changes as AE indicators” and “Seriousness criteria: the SAE triggers you must know”.
Is it aligned to ICH E6(R3)?
Yes. The course works from ICH E6(R3).
Does course access expire?
No. Access is yours for good. The CRC credential the track awards is valid for two years.
Study Safety Reporting and Pharmacovigilance for CRCs,within the CRC track.
One enrollment opens all eight courses, every final exam and the certificate. Course access does not expire.
Not separately. Safety Reporting and Pharmacovigilance for CRCs is the seventh course in the Clinical Research Coordinator track, and the track is enrolled in as one: all eight courses, every final exam and the certificate, for one payment of $249 USD.
Can I read any of it before I enroll?
Yes. Two lessons are open now: “Physical assessment and vital sign changes as AE indicators” and “Seriousness criteria: the SAE triggers you must know”.
Read two lessonsbefore you enroll.
Both are open now, exactly as enrolled learners read them. Every lesson in the course is written, cited and narrated the same way.
Module II · Lesson 224 min
Physical assessment and vital sign changes as AE indicators
Learn when vital sign changes and physical examination findings become reportable adverse events through clinical significance assessment and protocol-specific thresholds.
Seriousness criteria: the SAE triggers you must know
Apply the seven SAE seriousness criteria in operational depth, including the important medical event clause and hospitalization nuances that challenge even experienced CRCs.